BPG is committed to discovery and dissemination of knowledge
Featured Articles
5/11/2021 11:39:35 AM | Browse: 670 | Download: 1359
 |
Received |
|
2021-01-05 14:43 |
|
Peer-Review Started |
|
2021-01-05 14:44 |
|
First Decision by Editorial Office Director |
|
2021-01-17 04:50 |
|
Return for Revision |
|
2021-01-17 04:50 |
|
Revised |
|
2021-01-21 17:25 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-03-04 13:36 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-03-07 03:57 |
|
Articles in Press |
|
2021-03-07 03:57 |
|
Edit the Manuscript by Language Editor |
|
2021-04-06 04:40 |
|
Typeset the Manuscript |
|
2021-04-28 18:41 |
|
Publish the Manuscript Online |
|
2021-05-11 11:07 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Effectiveness of adjunctive corticosteroid therapy in patients with severe COVID-19: A retrospective cohort study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Bin Xiong, Li-Min He, Yuan-Yuan Qin, Hu Du, Zhu Zhan, Yi-Hong Zhou, Yao-Kai Chen and An Zhang |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Chongqing Special Research Project for Novel Coronavirus Pneumonia Prevention and Control |
cstc2020jscx-fyzxX0012 |
| Emergency Research Project of COVID-19 of Chongqing Health Commission |
2020NCPZX04 |
| Chongqing Special Research Project for Novel Coronavirus Pneumonia Prevention and Control |
cstc2020jscx-fyzx0074 |
|
| Corresponding Author |
An Zhang, MD, PhD, Chief Doctor, Professor, Department of Critical Care Medcine, The Second Affiliated Hospital of Chongqing Medical University, 74 Linjiang Road, Yuzhong District, Chongqing, China, Chongqing 400010, China. 300704@hospital.cqmu.edu.cn |
| Key Words |
COVID-19; Corticosteroid; SARS-COV-2; Outcomes |
| Core Tip |
Corticosteroids were used in the treatment of severe acute respiratory syndrome, Middle East respiratory syndrome and coronavirus disease 2019 (COVID-19) in the past. Many studies believe that corticosteroids have an inhibitory effect on inflammatory factors caused by viruses. In this study, 75 patients with severe COVID-19 were studied and divided into either a treatment group or a control group according to corticosteroid use. We found that adjunctive corticosteroid use did not significantly improve clinical outcomes in severe COVID-19 patients, but might promote the absorption of pulmonary lesions. |
| Publish Date |
2021-05-11 11:07 |
| Citation |
Xiong B, He LM, Qin YY, Du H, Zhan Z, Zhou YH, Chen YK, Zhang A. Effectiveness of adjunctive corticosteroid therapy in patients with severe COVID-19: A retrospective cohort study. World J Clin Cases 2021; 9(15): 3546-3558 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i15/3546.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i15.3546 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
